CIZUMAB 400MG INJECTION

About

Cizumab 400mg Injection is a cutting-edge monoclonal antibody (mAb) designed to specifically target and interfere with proteins essential for cancer growth and progression. As a form of targeted therapy, its action is highly precise, aiming to disrupt the intricate signaling pathways that cancer cells exploit for their survival and uncontrolled proliferation. Depending on its specific molecular target, Cizumab may function by inhibiting angiogenesis – the vital process of new blood vessel formation that tumors require for nutrient supply and growth – or by modulating the immune system to enhance its ability to recognize and destroy cancer cells. This focused therapeutic strategy allows for a more selective attack on malignant cells or their supportive microenvironment, often resulting in a more favorable side effect profile compared to traditional cytotoxic agents. It is administered intravenously under strict medical supervision, typically as part of a comprehensive cancer treatment plan.

Uses

• Treatment of various solid tumors, often in combination with chemotherapy.
• Management of metastatic colorectal cancer.
• Treatment of non-small cell lung cancer.
• Management of renal cell carcinoma.

Directions For Use

Cizumab 400mg Injection is administered intravenously by a healthcare professional. The dosage and infusion schedule will be determined by your doctor based on your condition.

Benefits

• Targeted action against cancer pathways.
• Improved overall survival in specific cancers.
• Can enhance the efficacy of chemotherapy.
• Reduced systemic toxicity compared to broad chemotherapy.
• Effective in advanced or metastatic settings.
• Specific mechanism of action.

Side Effects

• Hypertension
• Proteinuria
• Fatigue
• Diarrhea
• Nausea
• Headache
• Bleeding events
• Thromboembolic events
• Wound healing complications
• Infusion-related reactions
• Taste alteration
• Skin rash

Safety Measures

• Alcohol - No specific contraindication, but general moderation is advised, especially if experiencing gastrointestinal side effects.
• Pregnancy - Contraindicated during pregnancy due to potential teratogenic effects; women of childbearing potential must use effective contraception.
• Breastfeeding - Not recommended during treatment and for several months after the last dose, as the drug may be excreted in breast milk.
• Liver - Use with caution in patients with severe liver impairment; liver function should be monitored regularly during treatment.
• Kidney - Monitor for proteinuria and kidney function; dose adjustments may be considered in severe renal impairment.
• Lung - Monitor for new or worsening respiratory symptoms, as rare cases of pulmonary hemorrhage or interstitial lung disease have been reported.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.